Global Monoclonal Antibodies Product Market Research Report 2023

The global Monoclonal Antibodies Product market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Monoclonal Antibodies Product is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Monoclonal Antibodies Product is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Monoclonal Antibodies Product in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Monoclonal Antibodies Product include AbbVie, Roche, Johnson & Johnson, Amgen, Merck, Pfizer, Novartis, Eli Lilly and GlaxoSmithKline, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibodies Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibodies Product.

The Monoclonal Antibodies Product market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Monoclonal Antibodies Product market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monoclonal Antibodies Product companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Monoclonal Antibodies Product Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Cancer

1.2.3 Autoimmune Diseases

1.2.4 Infection

1.2.5 Hematological Diseases

1.2.6 Others

1.3 Market by Application

1.3.1 Global Monoclonal Antibodies Product Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Academic Institutes

1.3.4 Clinics

1.3.5 Diagnostic Laboratories

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Monoclonal Antibodies Product Market Perspective (2018-2029)

2.2 Monoclonal Antibodies Product Growth Trends by Region

2.2.1 Global Monoclonal Antibodies Product Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Monoclonal Antibodies Product Historic Market Size by Region (2018-2023)

2.2.3 Monoclonal Antibodies Product Forecasted Market Size by Region (2024-2029)

2.3 Monoclonal Antibodies Product Market Dynamics

2.3.1 Monoclonal Antibodies Product Industry Trends

2.3.2 Monoclonal Antibodies Product Market Drivers

2.3.3 Monoclonal Antibodies Product Market Challenges

2.3.4 Monoclonal Antibodies Product Market Restraints

3.1 Global Top Monoclonal Antibodies Product Players by Revenue

3.1.1 Global Top Monoclonal Antibodies Product Players by Revenue (2018-2023)

3.1.2 Global Monoclonal Antibodies Product Revenue Market Share by Players (2018-2023)

3.2 Global Monoclonal Antibodies Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Monoclonal Antibodies Product Revenue

3.4 Global Monoclonal Antibodies Product Market Concentration Ratio

3.4.1 Global Monoclonal Antibodies Product Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibodies Product Revenue in 2022

3.5 Monoclonal Antibodies Product Key Players Head office and Area Served

3.6 Key Players Monoclonal Antibodies Product Product Solution and Service

3.7 Date of Enter into Monoclonal Antibodies Product Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Monoclonal Antibodies Product Historic Market Size by Type (2018-2023)

4.2 Global Monoclonal Antibodies Product Forecasted Market Size by Type (2024-2029)

5.1 Global Monoclonal Antibodies Product Historic Market Size by Application (2018-2023)

5.2 Global Monoclonal Antibodies Product Forecasted Market Size by Application (2024-2029)

6.1 North America Monoclonal Antibodies Product Market Size (2018-2029)

6.2 North America Monoclonal Antibodies Product Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Monoclonal Antibodies Product Market Size by Country (2018-2023)

6.4 North America Monoclonal Antibodies Product Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Monoclonal Antibodies Product Market Size (2018-2029)

7.2 Europe Monoclonal Antibodies Product Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Monoclonal Antibodies Product Market Size by Country (2018-2023)

7.4 Europe Monoclonal Antibodies Product Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Monoclonal Antibodies Product Market Size (2018-2029)

8.2 Asia-Pacific Monoclonal Antibodies Product Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Monoclonal Antibodies Product Market Size by Region (2018-2023)

8.4 Asia-Pacific Monoclonal Antibodies Product Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Monoclonal Antibodies Product Market Size (2018-2029)

9.2 Latin America Monoclonal Antibodies Product Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Monoclonal Antibodies Product Market Size by Country (2018-2023)

9.4 Latin America Monoclonal Antibodies Product Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Monoclonal Antibodies Product Market Size (2018-2029)

10.2 Middle East & Africa Monoclonal Antibodies Product Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Monoclonal Antibodies Product Market Size by Country (2018-2023)

10.4 Middle East & Africa Monoclonal Antibodies Product Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 AbbVie

11.1.1 AbbVie Company Detail

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Monoclonal Antibodies Product Introduction

11.1.4 AbbVie Revenue in Monoclonal Antibodies Product Business (2018-2023)

11.1.5 AbbVie Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche Monoclonal Antibodies Product Introduction

11.2.4 Roche Revenue in Monoclonal Antibodies Product Business (2018-2023)

11.2.5 Roche Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Detail

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Monoclonal Antibodies Product Introduction

11.3.4 Johnson & Johnson Revenue in Monoclonal Antibodies Product Business (2018-2023)

11.3.5 Johnson & Johnson Recent Development

11.4 Amgen

11.4.1 Amgen Company Detail

11.4.2 Amgen Business Overview

11.4.3 Amgen Monoclonal Antibodies Product Introduction

11.4.4 Amgen Revenue in Monoclonal Antibodies Product Business (2018-2023)

11.4.5 Amgen Recent Development

11.5 Merck

11.5.1 Merck Company Detail

11.5.2 Merck Business Overview

11.5.3 Merck Monoclonal Antibodies Product Introduction

11.5.4 Merck Revenue in Monoclonal Antibodies Product Business (2018-2023)

11.5.5 Merck Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Detail

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Monoclonal Antibodies Product Introduction

11.6.4 Pfizer Revenue in Monoclonal Antibodies Product Business (2018-2023)

11.6.5 Pfizer Recent Development

11.7 Novartis

11.7.1 Novartis Company Detail

11.7.2 Novartis Business Overview

11.7.3 Novartis Monoclonal Antibodies Product Introduction

11.7.4 Novartis Revenue in Monoclonal Antibodies Product Business (2018-2023)

11.7.5 Novartis Recent Development

11.8 Eli Lilly

11.8.1 Eli Lilly Company Detail

11.8.2 Eli Lilly Business Overview

11.8.3 Eli Lilly Monoclonal Antibodies Product Introduction

11.8.4 Eli Lilly Revenue in Monoclonal Antibodies Product Business (2018-2023)

11.8.5 Eli Lilly Recent Development

11.9 GlaxoSmithKline

11.9.1 GlaxoSmithKline Company Detail

11.9.2 GlaxoSmithKline Business Overview

11.9.3 GlaxoSmithKline Monoclonal Antibodies Product Introduction

11.9.4 GlaxoSmithKline Revenue in Monoclonal Antibodies Product Business (2018-2023)

11.9.5 GlaxoSmithKline Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Monoclonal Antibodies Product Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Cancer

    Table 3. Key Players of Autoimmune Diseases

    Table 4. Key Players of Infection

    Table 5. Key Players of Hematological Diseases

    Table 6. Key Players of Others

    Table 7. Global Monoclonal Antibodies Product Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Monoclonal Antibodies Product Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Monoclonal Antibodies Product Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Monoclonal Antibodies Product Market Share by Region (2018-2023)

    Table 11. Global Monoclonal Antibodies Product Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Monoclonal Antibodies Product Market Share by Region (2024-2029)

    Table 13. Monoclonal Antibodies Product Market Trends

    Table 14. Monoclonal Antibodies Product Market Drivers

    Table 15. Monoclonal Antibodies Product Market Challenges

    Table 16. Monoclonal Antibodies Product Market Restraints

    Table 17. Global Monoclonal Antibodies Product Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Monoclonal Antibodies Product Market Share by Players (2018-2023)

    Table 19. Global Top Monoclonal Antibodies Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibodies Product as of 2022)

    Table 20. Ranking of Global Top Monoclonal Antibodies Product Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Monoclonal Antibodies Product Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Monoclonal Antibodies Product Product Solution and Service

    Table 24. Date of Enter into Monoclonal Antibodies Product Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Monoclonal Antibodies Product Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Monoclonal Antibodies Product Revenue Market Share by Type (2018-2023)

    Table 28. Global Monoclonal Antibodies Product Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Monoclonal Antibodies Product Revenue Market Share by Type (2024-2029)

    Table 30. Global Monoclonal Antibodies Product Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Monoclonal Antibodies Product Revenue Market Share by Application (2018-2023)

    Table 32. Global Monoclonal Antibodies Product Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Monoclonal Antibodies Product Revenue Market Share by Application (2024-2029)

    Table 34. North America Monoclonal Antibodies Product Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Monoclonal Antibodies Product Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Monoclonal Antibodies Product Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Monoclonal Antibodies Product Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Monoclonal Antibodies Product Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Monoclonal Antibodies Product Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Monoclonal Antibodies Product Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Monoclonal Antibodies Product Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Monoclonal Antibodies Product Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Monoclonal Antibodies Product Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Monoclonal Antibodies Product Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Monoclonal Antibodies Product Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Monoclonal Antibodies Product Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Monoclonal Antibodies Product Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Monoclonal Antibodies Product Market Size by Country (2024-2029) & (US$ Million)

    Table 49. AbbVie Company Detail

    Table 50. AbbVie Business Overview

    Table 51. AbbVie Monoclonal Antibodies Product Product

    Table 52. AbbVie Revenue in Monoclonal Antibodies Product Business (2018-2023) & (US$ Million)

    Table 53. AbbVie Recent Development

    Table 54. Roche Company Detail

    Table 55. Roche Business Overview

    Table 56. Roche Monoclonal Antibodies Product Product

    Table 57. Roche Revenue in Monoclonal Antibodies Product Business (2018-2023) & (US$ Million)

    Table 58. Roche Recent Development

    Table 59. Johnson & Johnson Company Detail

    Table 60. Johnson & Johnson Business Overview

    Table 61. Johnson & Johnson Monoclonal Antibodies Product Product

    Table 62. Johnson & Johnson Revenue in Monoclonal Antibodies Product Business (2018-2023) & (US$ Million)

    Table 63. Johnson & Johnson Recent Development

    Table 64. Amgen Company Detail

    Table 65. Amgen Business Overview

    Table 66. Amgen Monoclonal Antibodies Product Product

    Table 67. Amgen Revenue in Monoclonal Antibodies Product Business (2018-2023) & (US$ Million)

    Table 68. Amgen Recent Development

    Table 69. Merck Company Detail

    Table 70. Merck Business Overview

    Table 71. Merck Monoclonal Antibodies Product Product

    Table 72. Merck Revenue in Monoclonal Antibodies Product Business (2018-2023) & (US$ Million)

    Table 73. Merck Recent Development

    Table 74. Pfizer Company Detail

    Table 75. Pfizer Business Overview

    Table 76. Pfizer Monoclonal Antibodies Product Product

    Table 77. Pfizer Revenue in Monoclonal Antibodies Product Business (2018-2023) & (US$ Million)

    Table 78. Pfizer Recent Development

    Table 79. Novartis Company Detail

    Table 80. Novartis Business Overview

    Table 81. Novartis Monoclonal Antibodies Product Product

    Table 82. Novartis Revenue in Monoclonal Antibodies Product Business (2018-2023) & (US$ Million)

    Table 83. Novartis Recent Development

    Table 84. Eli Lilly Company Detail

    Table 85. Eli Lilly Business Overview

    Table 86. Eli Lilly Monoclonal Antibodies Product Product

    Table 87. Eli Lilly Revenue in Monoclonal Antibodies Product Business (2018-2023) & (US$ Million)

    Table 88. Eli Lilly Recent Development

    Table 89. GlaxoSmithKline Company Detail

    Table 90. GlaxoSmithKline Business Overview

    Table 91. GlaxoSmithKline Monoclonal Antibodies Product Product

    Table 92. GlaxoSmithKline Revenue in Monoclonal Antibodies Product Business (2018-2023) & (US$ Million)

    Table 93. GlaxoSmithKline Recent Development

    Table 94. Research Programs/Design for This Report

    Table 95. Key Data Information from Secondary Sources

    Table 96. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Monoclonal Antibodies Product Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Monoclonal Antibodies Product Market Share by Type: 2022 VS 2029

    Figure 3. Cancer Features

    Figure 4. Autoimmune Diseases Features

    Figure 5. Infection Features

    Figure 6. Hematological Diseases Features

    Figure 7. Others Features

    Figure 8. Global Monoclonal Antibodies Product Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Monoclonal Antibodies Product Market Share by Application: 2022 VS 2029

    Figure 10. Hospitals Case Studies

    Figure 11. Academic Institutes Case Studies

    Figure 12. Clinics Case Studies

    Figure 13. Diagnostic Laboratories Case Studies

    Figure 14. Monoclonal Antibodies Product Report Years Considered

    Figure 15. Global Monoclonal Antibodies Product Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 16. Global Monoclonal Antibodies Product Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Monoclonal Antibodies Product Market Share by Region: 2022 VS 2029

    Figure 18. Global Monoclonal Antibodies Product Market Share by Players in 2022

    Figure 19. Global Top Monoclonal Antibodies Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibodies Product as of 2022)

    Figure 20. The Top 10 and 5 Players Market Share by Monoclonal Antibodies Product Revenue in 2022

    Figure 21. North America Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. North America Monoclonal Antibodies Product Market Share by Country (2018-2029)

    Figure 23. United States Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Canada Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Monoclonal Antibodies Product Market Share by Country (2018-2029)

    Figure 27. Germany Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. France Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. U.K. Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Italy Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Russia Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Nordic Countries Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Monoclonal Antibodies Product Market Share by Region (2018-2029)

    Figure 35. China Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Japan Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. South Korea Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Southeast Asia Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. India Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Australia Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Monoclonal Antibodies Product Market Share by Country (2018-2029)

    Figure 43. Mexico Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Brazil Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Monoclonal Antibodies Product Market Share by Country (2018-2029)

    Figure 47. Turkey Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Saudi Arabia Monoclonal Antibodies Product Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. AbbVie Revenue Growth Rate in Monoclonal Antibodies Product Business (2018-2023)

    Figure 50. Roche Revenue Growth Rate in Monoclonal Antibodies Product Business (2018-2023)

    Figure 51. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibodies Product Business (2018-2023)

    Figure 52. Amgen Revenue Growth Rate in Monoclonal Antibodies Product Business (2018-2023)

    Figure 53. Merck Revenue Growth Rate in Monoclonal Antibodies Product Business (2018-2023)

    Figure 54. Pfizer Revenue Growth Rate in Monoclonal Antibodies Product Business (2018-2023)

    Figure 55. Novartis Revenue Growth Rate in Monoclonal Antibodies Product Business (2018-2023)

    Figure 56. Eli Lilly Revenue Growth Rate in Monoclonal Antibodies Product Business (2018-2023)

    Figure 57. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibodies Product Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed